As a precautionary measure, Camber Pharmaceuticals, Inc. is voluntarily recalling all unexpired lots of Valsartan Tablets, USP, 40mg, 80mg, 160mg and 320mg to the hospital, retail and consumer level. This recall of multiple batches of Valsartan Tablets was prompted due to the detection of trace amounts of N-Nitrosodimethylamine (NDMA), a possible process impurity or contaminant in an active pharmaceutical ingredient, manufactured by Hetero Labs Limited, Unit – I (API manufacturer).
View the full article from the FDA.
Camber Pharmaceuticals, Inc. Issues Voluntary Nationwide Recall of Valsarta
No replies to this topic
0 user(s) are reading this topic
0 members, 0 guests, 0 anonymous users